Zuclopenthixol Ong-Acting Im Injection (Depot) 200 mg/mL, 500 mg/mL Suppliers & Bulk Manufacturers
Available Forms: Long-acting IM Injection (Depot)
Available Strengths: 200 mg/mL, 500 mg/mL
Reference Brands: Clopixol Depot®(US)
Category: Antipsychotropic Drugs
Zuclopenthixol is a typical antipsychotic that works by blocking dopamine (D2) receptors in the brain, reducing psychotic symptoms. It’s primarily used as a long-acting intramuscular injection to manage schizophrenia, particularly in patients with poor medication compliance. It helps maintain symptom control over extended periods.
Product Description: Zuclopenthixol long-acting IM injection, a typical antipsychotic depot formulation, is not FDA-approved in the United States but is widely authorized in the EU under the brand Clopixol Depot. In Europe, it follows EMA guidelines for long-acting injectable neuroleptics, indicated for schizophrenia and related psychoses. EU compliance requires GMP manufacturing, stability data, and pharmacovigilance alignment. U.S. market entry may involve a 505(b)(2) pathway and complete ANDA dossier. To explore dossier-ready forms, formulations, and global suppliers of Zuclopenthixol long-acting IM injection, visit Pharmatradz.com.
Zuclopenthixol Ong-Acting Im Injection (Depot) — third party manufacturing & bulk supply
Zuclopenthixol Ong-Acting Im Injection (Depot) 200 mg/mL, 500 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Zuclopenthixol Ong-Acting Im Injection (Depot) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Zuclopenthixol Ong-Acting Im Injection (... →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Lithium Carbonate
Strength:
150 mg, 300 mg, 600 mg
Form: Tablets
Reference Brands: Lithobid (USA/LATAM), Priadel (EU)
View DetailsPhenobarbital Sodium
Strength:
65 mg/mL, 130 mg/mL.
Form: Injection
Reference Brands: Generic formulations marketed under different names
View DetailsQuick Response Guaranteed | Verified Suppliers